What We're Reading: Page 192
Industry reads hand-picked by our editors
Jun 10, 2020
-
The Wall Street Journal
Coronavirus Vaccine Candidates' Pivotal U.S. Testing to Start This Summer
-
The Harvard Crimson
Former Chemistry Chair Lieber Indicted by Federal Grand Jury for Making False Statements Regarding Relations to China
-
Science
Three big studies dim hopes that hydroxychloroquine can treat or prevent COVID-19
Jun 09, 2020
Jun 08, 2020
-
Bloomberg
AstraZeneca Approaches Gilead About Potential Merger
-
The New York Times
U.K. Lab to Sidestep Drug Industry to Sell Potential Virus Vaccine
-
STAT
Researcher has faculty appointment terminated after Lancet retraction
-
Reuters
Europe wants to make its own drugs, but it needs American blood plasma
Jun 05, 2020
-
STAT
Longtime exec Tony Coles on biotech, racism, and opportunities for change
-
Science
Two elite medical journals retract coronavirus papers over data integrity questions
-
Reuters
Abbvie strikes partnership to develop COVID-19 antibody therapy
-
Politico
FDA struggles to remain independent amid race for virus cure
Jun 04, 2020
Jun 03, 2020
Jun 02, 2020
-
CNBC
Merck CEO Kenneth Frazier: George Floyd 'could be me'
-
Associated Press
China delayed releasing coronavirus info, frustrating WHO
-
Bloomberg
Long-Delayed Drug-Price Bill Not Dead Yet, Grassley Says
-
South China Morning Post
China building secure facilities to fast track coronavirus vaccine production
Previous
